AI assistant
Acticor Biotech — Capital/Financing Update 2022
Jul 11, 2022
1070_rns_2022-07-11_8abae1fe-af6c-44e4-a9e3-ee5bbc30c2e7.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
HALF-YEAR REPORT ON THE LIQUIDITY CONTRACT WITH THE BROKERAGE FIRM KEPLER CHEUVREUX
COMMUNIQUE DE PRESSE
Paris, France, July 11, 2022 at 06:30 pm CEST - ACTICOR BIOTECH (ISIN: FR0014005OJ5 – ALACT), a clinical stage biopharmaceutical company dedicated to the development of innovative treatments for cardiovascular emergencies, today announces its half-year report on the liquidity contract with the brokerage firm Kepler Cheuvreux.
Under the liquidity contract entered into between ACTICOR BIOTECH and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2022:
- 44,453 shares
- € 320,248.35
- Number of executions on buy side on semester: 474
- Number of executions on sell side on semester: 454
- Traded volume on buy side on semester: 46,043 shares for € 311,966.95
- Traded volume on sell side on semester: 63,621 shares for € 440,978.86
As a reminder:
- the following resources appeared on the last half year statement on 31 December 2021 on the liquidity account:
- 62,031 shares
- € 191,956.52
- Number of executions on buy side on semester: 264
- Number of executions on sell side on semester: 42
- Traded volume on buy side on semester: 67,876 shares for € 445,195.95
- Traded volume on sell side on semester: 5,845 shares for € 37,412.21
- the following resources appeared on the liquidity account when the activity started:
- 0 shares
- € 600,000.00
The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd, 2021, renewing the implementation of liquidity contracts for shares as an accepted market practice.
About ACTICOR BIOTECH
Acticor Biotech is a clinical stage biopharmaceutical company, a spin-off from INSERM (the French National Institute of Health and Medical Research), that is developing an innovative treatment for acute thrombotic diseases, including ischemic strokes.
Acticor Biotech is developing glenzocimab (ACT017), a humanized monoclonal antibody fragment (Fab) directed against a novel target of major interest, platelet glycoprotein VI (GPVI). Glenzocimab inhibits platelet binding to the thrombus without affecting physiological hemostasis, thereby limiting the risk of bleeding, particularly intracerebral hemorrhage.
In May 2022, Acticor Biotech presented positive results from its Phase 1b/2a study, ACTIMIS, at the European Stroke Organisation Conference (ESOC 2022), confirming the safety profile and showing a reduction in mortality and intracerebral hemorrhage in the glenzocimab-treated group in patients with stroke. The efficacy of glenzocimab is now being evaluated in an international Phase 2/3 study, ACTISAVE, which will include 1,000 patients.
Acticor Biotech is supported by a panel of European and International Investors (Karista, Go Capital, Newton Biocapital, CMS Medical Venture Investment (HK) Limited, A&B (HK) Limited, Mirae Asset Capital, Anaxago, Primer Capital, Mediolanum farmaceutici and the Armesa foundation). Acticor Biotech is listed on Euronext Growth Paris, since November 2021 (ISIN: FR0014005OJ5 – ALACT).
For further information, please go to www.acticor-biotech.com
Contacts
ACTICOR BIOTECH Gilles AVENARD, MD CEO and Founder [email protected] T. : +33 (0)6 76 23 38 13
Sophie BINAY, PhD General Manager and CSO [email protected] T. : +33 (0)6 76 23 38 13
NewCap Mathilde BOHIN / Olivier BRICAUD Investor Relations [email protected] T. : +33 (0)1 44 71 94 95
Appendix
| Buy Side | ||||||
|---|---|---|---|---|---|---|
| Number of executions |
Number of shares |
Traded volume in EUR | Number of executions |
Sell Side Number of shares |
Traded volume in EUR | |
| Total | 474 | 46,043 | 311,966.95 | 454 | 63,621 | 440,978.86 |
| 03/01/2022 | 5 | 154 | 705.32 | 3 | 558 | 2,577.96 |
| 04/01/2022 | - | - | - | 3 | 130 | 611.00 |
| 05/01/2022 | - | - | - | 9 | 390 | 1,856.40 |
| 06/01/2022 | 1 | 1 | 4.70 | - | - | - |
| 07/01/2022 | 1 | 116 | 545.20 | 1 | 107 | 513.60 |
| 10/01/2022 | - | - | - | 3 | 273 | 1,310.40 |
| 11/01/2022 | - | - | - | 3 | 23 | 110.40 |
| 12/01/2022 | - | - | - | 1 | 477 | 2,289.60 |
| 13/01/2022 | - | - | - | 19 | 2,400 | 12,048.00 |
| 14/01/2022 | - | - | - | 18 | 2,436 | 13,860.84 |
| 17/01/2022 | - | - | - | 21 | 1,263 | 7,830.60 |
| 18/01/2022 | - | - | - | 25 | 4,702 | 31,973.60 |
| 19/01/2022 | - | - | - | 3 | 800 | 5,520.00 |
| 20/01/2022 | 3 | 1,000 | 6,800.00 | - | - | - |
| 21/01/2022 | 10 | 801 | 5,126.40 | 1 | 1 | 6.50 |
| 24/01/2022 | 8 | 1,700 | 10,234.00 | - | - | - |
| 25/01/2022 | 12 | 1,492 | 8,847.56 | - | - | - |
| 26/01/2022 | 7 | 608 | 3,496.00 | - | - | - |
| 27/01/2022 | - | - | - | 2 | 40 | 236.00 |
| 28/01/2022 | 13 | 633 | 3,690.39 | - | - | - |
| 31/01/2022 | 3 | 167 | 968.60 | 1 | 60 | 354.00 |
| 01/02/2022 | 4 | 92 | 539.12 | 5 | 896 | 5,376.00 |
| 02/02/2022 | 5 | 401 | 2,438.08 | 6 | 1,056 | 6,504.96 |
| 03/02/2022 | 2 | 709 | 4,211.46 | 2 | 350 | 2,205.00 |
| 04/02/2022 | 4 | 300 | 1,830.00 | - | - | - |
| 07/02/2022 | 5 | 567 | 3,453.03 | - | - | - |
| 08/02/2022 | 7 | 490 | 2,959.60 | 1 | 1 | 6.06 |
| 09/02/2022 | 6 | 670 | 4,053.50 | - | - | - |
| 10/02/2022 | 6 | 210 | 1,264.20 | 1 | 1 | 6.04 |
| 11/02/2022 | 4 | 200 | 1,204.00 | 3 | 148 | 896.88 |
| 14/02/2022 | 4 | 326 | 1,939.70 | 1 | 1 | 6.02 |
| 15/02/2022 | 5 | 499 | 2,919.15 | 1 | 1 | 5.90 |
| 16/02/2022 | 2 | 46 | 266.80 | - | - | - |
| 17/02/2022 | 4 | 401 | 2,325.80 | 1 | 1 | 5.80 |
| 18/02/2022 | 9 | 595 | 3,433.15 | 1 | 1 | 5.80 |
| 21/02/2022 | 3 | 306 | 1,744.20 | - | - | - |
| 22/02/2022 | 3 | 400 | 2,240.00 | 4 | 315 | 1,795.50 |
| Buy Side | Sell Side | ||||||
|---|---|---|---|---|---|---|---|
| Number of executions |
Number of shares |
Traded volume in EUR | Number of executions |
Number of shares |
Traded volume in EUR | ||
| Total | 474 | 46,043 | 311,966.95 | 454 | 63,621 | 440,978.86 | |
| 23/02/2022 | 1 | 25 | 141.00 | 10 | 1,285 | 7,388.75 | |
| 24/02/2022 | 4 | 1,700 | 9,639.00 | 1 | 500 | 2,870.00 | |
| 25/02/2022 | 2 | 309 | 1,761.30 | 3 | 481 | 2,760.94 | |
| 28/02/2022 | - | - | - | 13 | 2,217 | 12,969.45 | |
| 01/03/2022 | - | - | - | 13 | 3,854 | 24,241.66 | |
| 02/03/2022 | - | - | - | 11 | 4,000 | 28,960.00 | |
| 04/03/2022 | - | - | - | 9 | 3,500 | 28,000.00 | |
| 07/03/2022 | - | - | - | 9 | 2,000 | 16,700.00 | |
| 08/03/2022 | - | - | - | 7 | 900 | 7,596.00 | |
| 09/03/2022 | 7 | 600 | 4,920.00 | - | - | - | |
| 10/03/2022 | 7 | 900 | 7,083.00 | 5 | 500 | 4,150.00 | |
| 11/03/2022 | 1 | 1 | 8.00 | 8 | 800 | 6,480.00 | |
| 14/03/2022 | 21 | 3,250 | 24,472.50 | - | - | - | |
| 15/03/2022 | 2 | 500 | 3,625.00 | 8 | 1,250 | 9,162.50 | |
| 16/03/2022 | - | - | - | 1 | 250 | 1,825.00 | |
| 17/03/2022 | 8 | 500 | 3,610.00 | 1 | 180 | 1,305.00 | |
| 18/03/2022 | 7 | 1,000 | 7,030.00 | - | - | - | |
| 21/03/2022 | 12 | 939 | 6,441.54 | 1 | 1 | 7.10 | |
| 22/03/2022 | 8 | 500 | 3,400.00 | 3 | 200 | 1,380.00 | |
| 23/03/2022 | 5 | 564 | 3,722.40 | - | - | - | |
| 24/03/2022 | - | - | - | 1 | 1 | 6.70 | |
| 25/03/2022 | 2 | 436 | 2,851.44 | 2 | 254 | 1,701.80 | |
| 28/03/2022 | 8 | 1,000 | 6,490.00 | 3 | 102 | 673.20 | |
| 29/03/2022 | 8 | 652 | 4,172.80 | 5 | 1,000 | 6,480.00 | |
| 30/03/2022 | 2 | 17 | 108.80 | 7 | 1,243 | 8,216.23 | |
| 31/03/2022 | 2 | 250 | 1,625.00 | 1 | 250 | 1,675.00 | |
| 01/04/2022 | 3 | 558 | 3,593.52 | 2 | 250 | 1,625.00 | |
| 04/04/2022 | 4 | 400 | 2,584.00 | - | - | - | |
| 05/04/2022 | - | - | - | 7 | 1,251 | 8,331.66 | |
| 06/04/2022 | 2 | 350 | 2,334.50 | 1 | 1 | 6.80 | |
| 07/04/2022 | 2 | 450 | 2,952.00 | 1 | 149 | 983.40 | |
| 08/04/2022 | 5 | 320 | 2,076.80 | 2 | 11 | 72.60 | |
| 11/04/2022 | 3 | 499 | 3,318.35 | 10 | 1,840 | 12,843.20 | |
| 12/04/2022 | 4 | 266 | 1,806.14 | 1 | 1 | 6.80 | |
| 13/04/2022 | 2 | 235 | 1,574.50 | - | - | - | |
| 14/04/2022 | 4 | 166 | 1,112.20 | 2 | 11 | 74.80 | |
| 19/04/2022 | 4 | 500 | 3,625.00 | 17 | 3,455 | 26,707.15 | |
| 20/04/2022 | 8 | 1,250 | 9,325.00 | 5 | 1,000 | 7,880.00 | |
| 21/04/2022 | 4 | 371 | 2,808.47 | 11 | 1,945 | 15,209.90 | |
| 22/04/2022 | 14 | 755 | 5,911.65 | 4 2 |
500 | 3,975.00 | |
| 25/04/2022 | 11 | 704 | 5,498.24 | - | - | - | |
| 26/04/2022 | 4 | 267 | 2,053.23 | 4 | 750 | 5,947.50 | |
| 27/04/2022 | 4 | 233 | 1,770.80 | - | - | - | |
| 28/04/2022 | 3 | 80 | 600.00 | 1 | 1 | 7.70 | |
| 29/04/2022 | 3 | 50 | 370.00 | 4 | 751 | 5,782.70 | |
| Buy Side | Sell Side | |||||
|---|---|---|---|---|---|---|
| Number of executions |
Number of shares |
Traded volume in EUR | Number of executions |
Number of shares |
Traded volume in EUR | |
| Total | 474 | 46,043 | 311,966.95 | 454 | 63,621 | 440,978.86 |
| 02/05/2022 | - | - | - | 13 | 2,100 | 16,884.00 |
| 03/05/2022 | - | - | - | 2 | 123 | 1,008.60 |
| 04/05/2022 | 5 | 261 | 2,088.00 | 9 | 1,378 | 11,451.18 |
| 05/05/2022 | 5 | 395 | 3,160.00 | 1 | 250 | 2,050.00 |
| 06/05/2022 | 10 | 1,041 | 8,244.72 | 1 | 1 | 8.20 |
| 09/05/2022 | 2 | 210 | 1,617.00 | 3 | 266 | 2,101.40 |
| 10/05/2022 | 2 | 126 | 970.20 | 5 | 228 | 1,778.40 |
| 11/05/2022 | - | - | - | 3 | 250 | 1,950.00 |
| 12/05/2022 | 4 | 251 | 1,932.70 | 1 | 1 | 7.72 |
| 13/05/2022 | 4 | 250 | 1,925.00 | 1 | 250 | 1,950.00 |
| 16/05/2022 | 10 | 1,200 | 8,892.00 | 3 | 500 | 3,825.00 |
| 17/05/2022 | 8 | 752 | 5,640.00 | 1 | 1 | 7.72 |
| 18/05/2022 | 1 | 250 | 1,825.00 | 1 | 1 | 7.60 |
| 19/05/2022 | 2 | 250 | 1,825.00 | - | - | - |
| 20/05/2022 | 16 | 2,250 | 15,682.50 | 3 | 251 | 1,807.20 |
| 23/05/2022 | 5 | 250 | 1,700.00 | 6 | 162 | 1,117.80 |
| 24/05/2022 | 2 | 16 | 107.20 | 2 | 251 | 1,706.80 |
| 25/05/2022 | - | - | - | 6 | 1,000 | 7,050.00 |
| 26/05/2022 | - | - | - | 5 | 250 | 1,775.00 |
| 27/05/2022 | 1 | 1 | 7.10 | 1 | 1 | 7.10 |
| 30/05/2022 | 6 | 500 | 3,525.00 | 2 | 101 | 727.20 |
| 31/05/2022 | 2 | 56 | 392.00 | 3 | 301 | 2,143.12 |
| 01/06/2022 | 6 | 696 | 4,844.16 | 1 | 1 | 7.02 |
| 02/06/2022 | 2 | 485 | 3,273.75 | 2 | 162 | 1,117.80 |
| 03/06/2022 | 2 | 500 | 3,400.00 | 8 | 888 | 6,224.88 |
| 06/06/2022 | 1 | 15 | 105.00 | 2 | 30 | 213.00 |
| 07/06/2022 | 6 | 245 | 1,715.00 | 1 | 1 | 7.08 |
| 08/06/2022 | 7 | 742 | 5,119.80 | 1 | 1 | 7.04 |
| 09/06/2022 | 1 | 250 | 1,700.00 | - | - | - |
| 10/06/2022 | 2 | 250 | 1,700.00 | 1 | 10 | 69.00 |
| 13/06/2022 | 1 | 250 | 1,675.00 | 2 | 16 | 108.96 |
| 14/06/2022 | 6 | 251 | 1,681.70 | 3 | 336 | 2,284.80 |
| 15/06/2022 | 5 | 251 | 1,681.70 | 4 | 20 | 136.00 |
| 16/06/2022 | 1 | 15 | 100.50 | - | - | - |
| 17/06/2022 | 2 | 31 | 207.70 | - | - | - |
| 20/06/2022 | 2 | 17 | 113.90 | 6 | 861 | 5,975.34 |
| 21/06/2022 | 4 | 251 | 1,731.90 | 2 | 10 | 70.00 |
| 22/06/2022 | 3 | 17 | 115.60 | 2 | 2 | 13.78 |
| 23/06/2022 | 2 | 17 | 115.60 | 5 | 170 | 1,173.00 |
| 24/06/2022 | 4 | 19 | 129.20 | 3 | 12 | 82.80 |
| 27/06/2022 | 1 | 15 | 102.00 | 5 2 |
68 | 469.20 |
| 28/06/2022 | 1 | 1 | 6.88 | 1 | 1 | 6.88 |
| 29/06/2022 | 3 | 185 | 1,258.00 | 1 | 1 | 6.84 |
| 30/06/2022 | - | - | - | 4 | 250 | 1,725.00 |